Document:

cphi10kex102123114.htm

 

 

Re: Service about being [Job Position] of China Pharma Holdings, Inc.

[Date/Month/Year]

Dear [             ],

On behalf of the Board of Directors (the “Board”) of China Pharma Holdings, Inc. (the “Company”), I am pleased to welcome you to join the Board as [Job Position]. I look forward to working with you. Your starting date will be the date on which the Board approves your engagement and your engagement for this term will end on the date of the next annual shareholders meeting.

Your compensation will consist of the following:

	
1)  

	
A retainer of $[        ] per year, payable quarterly within [  ] days of the end of the quarter;

	
2)  

	
Options to purchase [  ] shares of the Company’s common stock, par value $0.001 per share, with an exercise price $[  ] per share which is determined by the average stock price of [  ] days before [Date/Month/Year]. The options will vest on the anniversary date from the date the Board approves your appointment. The options granted is under the Company’s 2010 Long-Term Incentive Plan.

If you agree to the terms and conditions stated above, please sign and date this letter below.

I look forward to working with you and sincerely hope that your service will be enjoyable and rewarding.

Sincerely

Chairman of the Board

China Pharma Holdings, Inc.

Response:

This letter correctly sets forth the understanding of the recipient.

By: _____________________________

Date: ___________________________cphi10kex104123114.htm

Exhibit 10.4

 

Loans Extension Confirmation Letter

 

Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD44,213 respectively as of December 31, 2014. Due to the fact the Company temporarily did not have enough balance in its oversea account to repay the loans, both Ms. Tsui and the Company agreed to extend the loans to December 31, 2015, by which date the Company shall repay the principal and accumulated interest.

 

 

 

	 	 
Creditor:/s/ Heung Mei Tsui

 

Debtor:China Pharma Holdings, Inc.

 

                 By: Zhilin LinExhibit 10.2

Loan Agreement Summary

 

		1.	Lender and borrower:

 

		Borrower:	Weifang Lakeland Safety Products Co., Ltd. (“WF”)

		Lender:	Weifang Rural Credit Cooperative Bank (“WRCCB”)

 

		2.	The borrowing amounts limit: RMB 8 million, WF can select the borrowing amounts within RMB 8 million
(approximately USD $1,300,000).

 

		3.	Borrowing method: Trading financial, WF mortgaged inventory valued RMB 18,291,748 to the bank.
The bank hired a professional firm to supervise WF’s inventory flow, which WF will pay at a yearly rate of RMB 46,000.

 

		4.	Interests: Interest based on 120% of the benchmark rate. The annum interest rate is 6.42%. Monthly
interest is RMB 42,800 which will be paid monthly.

 

		5.	Borrowing period: up to six months. The longest borrowing period is six months beginning March
25, 2015 and ending September 21, 2015.EX-10.1

 Exhibit 10.1 

AMENDMENT TO EMPLOYMENT AND NON-COMPETITION AGREEMENT 

THIS AMENDMENT TO EMPLOYMENT AND NON-COMPETITION AGREEMENT (this “Agreement”) is made as of March 27, 2015, by and among
Brenda Galgano (the “Executive”), Vitamin Shoppe, Inc., a Delaware corporation (“Parent”), and Vitamin Shoppe Industries Inc., a New York corporation (the “Company”). 

Reference is made to that certain Employment and Non-Competition Agreement by and among the Executive, Parent and the Company dated
March 29, 2012 (the “Employment Agreement”). 
 WHEREAS, the parties to this Agreement desire to amend the Employment
Agreement as provided herein. 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows: 

1.     Section 1 of the Employment Agreement is hereby amended and restated in its entirety as follows: 

“1. Position and Responsibilities. The Executive shall continue to serve as Executive Vice President, Chief
Financial Officer of each of Parent and the Company and, in such capacity, shall be responsible for the general financial, affairs and management of Parent and the Company, shall perform such duties as are customarily performed by an officer with
similar responsibilities of a company of a similar size, together with such other responsibilities that may be assigned to her by the Chief Executive Officer and the Board of Directors of Parent or the Company, and shall have such power and
authority as shall reasonably be required to enable her to perform her duties hereunder; provided, however, that in exercising such power and authority and performing such duties, she shall at all times be subject to the authority of
the Chief Executive Officer and the Board of Directors of Parent and the Company. The Executive agrees to devote substantially all of her business time, attention and services to the diligent, faithful and competent discharge of such duties for the
successful operation of Parent’s and the Company’s business. Notwithstanding the foregoing, upon the approval of the Compensation Committee of Parent, the Executive may serve as a director of a publicly traded company that is not a
Competitive Business (hereinafter defined), provided that such service does not interfere with the Executive’s obligations hereunder.” 

2.     Section 2(A) of the Employment Agreement is hereby amended and restated in its entirety as follows: 

“(A) Salary. In consideration of the services to be rendered by the Executive to the Company, the Company shall
continue to pay to the Executive a base salary of four hundred seventy thousand dollars ($484,100) per annum (such 

  
 1 

 
salary as it may be increased from time to time being hereinafter referred to as the “Base Salary”). Except as may otherwise be agreed, the Base Salary shall be payable in
conformity with the Company’s customary practices for executive compensation as such practices shall be established or modified from time to time but shall be payable not less frequently than monthly. The Executive shall receive such increases
in her Base Salary as the Board of Directors of the Company may from time to time approve in its sole discretion; provided, however, that the Executive’s Base Salary shall be reviewed not less often than annually. The
Executive’s Base Salary may not be decreased without her written consent” 
 3.     Section 3 of the
Employment Agreement is hereby amended and restated in its entirety as follows: 
 “3. Term. The term of the
Executive’s employment hereunder shall commence on the Effective Date and shall terminate on March 31, 2016 (the “Term”), unless earlier terminated as provided in Section 5 of this Agreement.” 

4.     Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Employment
Agreement. 
 5.     This Agreement is an amendment to the Employment Agreement, and to the extent there is a
discrepancy between this Agreement and the Employment Agreement, this Agreement shall control and supersede the Employment Agreement to the extent of such discrepancy. The Employment Agreement otherwise remains in full force and effect. 

6.     This Agreement, the Employment Agreement (as further amended by this Agreement) and those documents expressly
referred to herein embody the complete agreement and understanding among the parties hereto and supersede and preempt any prior understandings, agreements or representations by or among the parties hereto, written or oral, which may have related to
the subject matter hereof in any way. 
 [REMAINDER OF PAGE INTENTIONALLY BLANK] 

  
 2 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
March 27, 2015. 
  

			
	EXECUTIVE
	
	 /s/ Brenda Galgano

	Brenda Galgano
	
	VITAMIN SHOPPE, INC.
		
	By:	 	 /s/ Jean Frydman

		 	 Jean Frydman
 Senior Vice President, General
Counsel
 and Corporate Secretary

	
	VITAMIN SHOPPE INDUSTRIES INC.
		
	By:	 	 /s/ Jean Frydman

		 	 Jean Frydman
 Senior Vice President, General
Counsel and Corporate Secretary

  
 3EX-10.2

 Exhibit 10.2 

AMENDMENT NO. 3 TO EMPLOYMENT AND NON-COMPETITION AGREEMENT 

THIS AMENDMENT NO. 3 TO EMPLOYMENT AND NON-COMPETITION AGREEMENT (this “Agreement”) is made as of March 27, 2015, by and
among Louis H. Weiss (the “Executive”), Vitamin Shoppe, Inc., a Delaware corporation (“Parent”), and Vitamin Shoppe Industries Inc., a New York corporation (the “Company”). 

Reference is made to that certain Employment and Non-Competition Agreement by and among the Executive, Parent and the Company dated
January 15, 2007, as amended by that certain Amendment to Employment and Non-Competition Agreement dated December 28, 2007 and that certain Amendment No. 2 to Employment and Non-Competition Agreement dated March 29, 2012
(collectively, the “Employment Agreement”). 
 WHEREAS, the parties to this Agreement desire to further amend the
Employment Agreement as provided herein. 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows: 

1.     Section 1 of the Employment Agreement is hereby amended and restated in its entirety as follows: 

“1. Position and Responsibilities. The Executive shall continue to serve as Executive Vice President, Chief
Merchandising and Marketing Officer of each of Parent and the Company and, in such capacity, shall perform such duties as are customarily performed by an officer with similar responsibilities of a company of a similar size, and shall have such power
and authority as shall reasonably be required to enable him to perform his duties hereunder; provided, however, that in exercising such power and authority and performing such duties, he shall at all times be subject to the authority
of the Chief Executive Officer and the Board of Directors of Parent and the Company. The Executive agrees to devote substantially all of his business time, attention and services to the diligent, faithful and competent discharge of such duties for
the successful operation of Parent’s and the Company’s business.” 
 2.     Section 2(A) of the
Employment Agreement is hereby amended and restated in its entirety as follows: 
 “(A) Salary. In consideration
of the services to be rendered by the Executive to the Company, the Company shall continue to pay to the Executive a base salary of four hundred fifty thousand dollars ($450,000) per annum (such salary as it may be increased from time to time being
hereinafter referred to as the “Base Salary”). Except as may otherwise be agreed, the Base Salary shall be payable in conformity with the Company’s customary practices for executive compensation as such practices shall be
established or modified from time to time but shall be payable not less frequently than monthly. The Executive shall receive 

  
 1 

 
such increases in his Base Salary as the Board of Directors of the Company may from time to time approve in its sole discretion; provided, however, that the Executive’s Base
Salary shall be reviewed not less often than annually. The Executive’s Base Salary may not be decreased without his written consent.” 

3.     Section 2(B) of the Employment Agreement is hereby amended and restated in its entirety as follows: 

“(B) Bonus Compensation. For each calendar year during the term of this Agreement, the Executive shall be eligible
for a cash bonus award (the “Annual Cash Bonus”) with a target amount of fifty percent (50%) of his then current Base Salary pursuant to the Company’s Management Incentive Program (“MIP”). As currently
constituted the MIP is based upon (i) the Company’s satisfaction of operating objectives specified by the Company’s Board of Directors each year in its sole discretion, and (ii) individual members of management’s
satisfaction of certain individual operating objectives based upon their area of responsibility as specified by the Company’s Board of Directors in their sole discretion. The Executive acknowledges that the Company reserves the right to change
the structure of the Annual Cash Bonus from time to time, provided that any change shall not affect the Executive’s ability to receive an Annual Cash Bonus of up to a target amount of fifty percent (50%) of the Executive’s Base
Salary. The Executive shall be paid his Annual Cash Bonus on or before March 1st of the calendar year following the year to which such bonus relates, but in all events on or before March 15th of such year. The parties hereto acknowledge
that the determination of the Annual Cash Bonus for the year in which the Executive’s employment terminates (and possibly for the prior year) shall not be known on the date the Executive’s employment terminates, and, if any, shall be paid
by the Company to the Executive not more than thirty (30) days after the determination thereof, but in all events on or before March 15th of the calendar year following the calendar year of termination. The Executive acknowledges and
agrees that as required under law or Company policy, incentive compensation to the extent received based on erroneous information, is subject to recoupment for a three (3)-year period in the event of an accounting restatement due to material
noncompliance by the Company with any financial reporting requirement under the federal securities laws.” 

4.     Section 3 of the Employment Agreement is hereby amended and restated in its entirety as follows: 

“3. Term. The term of the Executive’s employment hereunder shall commence on the Effective Date and shall
terminate on March 31, 2016 (the “Term”), unless earlier terminated as provided in Section 5 of this Agreement. For purposes of this Agreement, “Termination Date” shall mean the last day of the Term.”

  
 2 

 5.     Capitalized terms used but not defined herein shall have the
meanings ascribed to such terms in the Employment Agreement. 
 6.     This Agreement is an amendment to the
Employment Agreement, and to the extent there is a discrepancy between this Agreement and the Employment Agreement, this Agreement shall control and supersede the Employment Agreement to the extent of such discrepancy. The Employment Agreement
otherwise remains in full force and effect. 
 7.     This Agreement, the Employment Agreement (as further amended
by this Agreement) and those documents expressly referred to herein embody the complete agreement and understanding among the parties hereto and supersede and preempt any prior understandings, agreements or representations by or among the parties
hereto, written or oral, which may have related to the subject matter hereof in any way. 
 [REMAINDER OF PAGE INTENTIONALLY BLANK] 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
March 27, 2015. 
  

			
	EXECUTIVE
	
	 /s/ Louis H. Weiss

	Louis H. Weiss
	
	VITAMIN SHOPPE, INC.
		
	By:	 	 /s/ Jean Frydman

		 	 Jean Frydman
 Senior Vice President, General
Counsel
 and Corporate Secretary

	
	VITAMIN SHOPPE INDUSTRIES INC.
		
	By:	 	 /s/ Jean Frydman

		 	 Jean Frydman
 Senior Vice President, General
Counsel
 and Corporate Secretary

  
 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]